The Next Big Challenge

March 1, 2004

1 Min Read
The Next Big Challenge

Originally Published MX March/April 2004


With a product already approved for use in the European Union, OmniSonics offered its C round last September in the hope of generating enough capital to support further commercialization of its technology—including a projected U.S. product launch in 2004. The company's fund-raising success resulted in a $43 million round of funding that promises a strong transition into the commercial phase.

Pax: Explaining the plan of attack.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like